Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Enzinger

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Health News (Waltham, Mass.)|June 18, 2004
Should people with Barrett's esophagus, who are at risk for cancer of the esophagus, avoid alcohol?Peter C Enzinger
Health News (Waltham, Mass.)|July 9, 2004
Colon cancer surgeries compared. In patients with certain characteristics, laparoscopically assisted colectomy works wellPeter C Enzinger
The New England Journal of Medicine|December 6, 2003
Esophageal cancerPeter C Enzinger, Robert J Mayer
Seminars in Oncology|April 28, 2004
Gastrointestinal cancer in older patientsPeter C Enzinger, Robert J Mayer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Adjuvant therapy for gastric cancer: revisiting the past to clarify the futureGabriel A Brooks, Peter C Enzinger, Charles S Fuchs
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Is There a Precise Adjuvant Therapy for Esophagogastric Carcinoma?Elizabeth Cartwright, Florence K Keane, Peter C Enzinger, et al.
The Journal of Surgical Research|June 24, 2020
Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric CancerXuefei Wang, Junjie Zhao, Zhenbin Shen, et al.
Pharmacoeconomics|October 14, 2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's PerspectiveTingting Qu, Shujing Zhang, Yichen Zhong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2026
Analysis of quality-adjusted survival time without symptoms or toxicity for pembrolizumab plus chemotherapy as treatment for previously untreated participants with advanced or metastatic esophageal cancerYing Zhang, Marc Diez Garcia, Sukrut Shah, et al.
Practical Radiation Oncology|March 29, 2014
Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinomaShereef M Elnahal, Atul B Shinagare, Jackie Szymonifka, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Health News (Waltham, Mass.)|June 18, 2004
Should people with Barrett's esophagus, who are at risk for cancer of the esophagus, avoid alcohol?Peter C Enzinger
Health News (Waltham, Mass.)|July 9, 2004
Colon cancer surgeries compared. In patients with certain characteristics, laparoscopically assisted colectomy works wellPeter C Enzinger
The New England Journal of Medicine|December 6, 2003
Esophageal cancerPeter C Enzinger, Robert J Mayer
Seminars in Oncology|April 28, 2004
Gastrointestinal cancer in older patientsPeter C Enzinger, Robert J Mayer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Adjuvant therapy for gastric cancer: revisiting the past to clarify the futureGabriel A Brooks, Peter C Enzinger, Charles S Fuchs
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Is There a Precise Adjuvant Therapy for Esophagogastric Carcinoma?Elizabeth Cartwright, Florence K Keane, Peter C Enzinger, et al.
The Journal of Surgical Research|June 24, 2020
Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric CancerXuefei Wang, Junjie Zhao, Zhenbin Shen, et al.
Pharmacoeconomics|October 14, 2022
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's PerspectiveTingting Qu, Shujing Zhang, Yichen Zhong, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2026
Analysis of quality-adjusted survival time without symptoms or toxicity for pembrolizumab plus chemotherapy as treatment for previously untreated participants with advanced or metastatic esophageal cancerYing Zhang, Marc Diez Garcia, Sukrut Shah, et al.
Practical Radiation Oncology|March 29, 2014
Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinomaShereef M Elnahal, Atul B Shinagare, Jackie Szymonifka, et al.
Pageof 10